Treatment with secretin and a cholecystokinin-like peptide in patients with pancreatic cancer. A pilot study.

Abstract

Secretin and cholecystokinin (CCK) have trophic effects on the pancreas and may therefore have a place in the treatment of pancreatic cancer. The present study was performed to examine whether these hormones may cause harm in patients with pancreatic cancer receiving cytostatics. The cytostatics were 5-fluorouracil, adriamycin, and mitomycin C(FAM… (More)

Topics

Cite this paper

@article{Steffensrud1984TreatmentWS, title={Treatment with secretin and a cholecystokinin-like peptide in patients with pancreatic cancer. A pilot study.}, author={S Steffensrud and Hans Erichsen and P R\oysland and Tore B Halvorsen and Rigmor Klepp and Olbj\orn Harald Klepp and Erick W{\"u}nsch and H. Petersen}, journal={Scandinavian journal of gastroenterology}, year={1984}, volume={19 7}, pages={909-15} }